RCGHX Mutual Fund

RCGHX Mutual Fund

NAV$17.21

Fund Essentials - as of Mar 31, 2026

Net Assets
$1M
Expense Ratio
2.16%
Dividend Yield (Current)
-
Holdings
24
Inception Date
Feb 5, 2002
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Unspecified

Performance

YTD+0.35%
1 Year+12.78%
3 Year+1.39%
5 Year+7.77%
10 Year+15.08%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company13.30%
MCKMckesson Corp.15.57%
ABBVAbbvie Inc Health Care5.09%
VRTXVertex Pharmaceuticals Inc5.09%
MRKMerck & Co. Inc.5.05%
Top 10 Concentration: 55.84%Report Date: Mar 31, 2026
Download all 24 holdings for RCGHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$7.49
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how RCGHX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

RCGHX Mutual Fund Overview

RCGHX Mutual Fund (Virtus KAR Health Sciences Fund Class C) is managed by Virtus Investment Partners with $1.1M in net assets. RCGHX expense ratio is 2.16%, holding 24 positions across sectors including Health Care, Consumer Staples. Inception date: 2002-02-05.

RCGHX performance shows a YTD return of 0.35%. The 1-year return is 12.78% and the 5-year return is 7.77%.

RCGHX top holdings include Eli Lilly And Company (13.3%), Mckesson Corp.1 (5.6%), Abbvie Inc Health Care (5.1%), Vertex Pharmaceuticals Inc (5.1%), Merck & Co. Inc. (5.0%). Go to all RCGHX holdings, RCGHX sectors, or RCGHX dividends.

RCGHX can be compared against other funds. Use RCGHX overlap to find shared positions, or RCGHX vs another fund for a side-by-side view. RCGHX alternatives are available via the screener, along with tax-loss harvesting opportunities.